Expression of Bcl-2 and Bax proteins in relation to quality of bovine oocytes and embryos produced in vitro.

The mechanisms underlying the visual assessment and selection of immature oocytes resulting in optimum embryonic development following in vitro maturation, fertilization and culture (in vitro maturation (IVM)/in vitro fertilization (IVF)/in vitro embryo culture (IVC)) are unknown. Also, the reasons for the more frequent occurrence of cytoplasmic fragmentation in in vitro produced bovine embryos, resulting in poor survival following cryopreservation and decreased pregnancy rates following embryo transfer are not clear. The objectives of this study are: (1) to investigate whether differences in the quality of immature oocytes and embryo fragmentation are associated with apoptosis; and (2) to study the pattern of Bcl-2 and Bax expression in oocytes and embryos to help elucidate their potential roles in the regulation of apoptosis during development. Bovine oocytes were obtained from slaughterhouse ovaries and divided into four grades (grades I-IV) based on their morphology. Oocytes of different grades were cultured in serum-free medium for 48h. Embryos were produced only from grade I oocytes (highest quality) via IVM, IVF and IVC procedures. The morphological analysis of apoptosis in oocytes and embryos was carried out using propidium iodide staining and terminal deoxynucleotidyl transferase mediated dUTP nick end labeling. The expression of Bcl-2 and Bax in oocytes and embryos of different qualities and stages was determined using western blotting. The results showed that the number of morphologically abnormal oocytes with shrinkage and/or fragmentation of the ooplasm, which are typical features of apoptosis, was significantly higher in grade IV oocytes (denuded oocytes, the lowest quality) than in grade I oocytes after 48h in vitro culture (P<0.05). DNA fragmentation, a hallmark of the biochemical changes seen in apoptotic cell death, was observed in morphologically fragmented oocytes and embryos. The expression of Bcl-2 was high in good quality oocytes and embryos, low in fragmented embryos, and hardly detectable in denuded oocytes. In contrast, the expression of Bax was found in all types of oocytes and embryos with the highest expression in the denuded oocytes. This implies that the ratio of Bcl-2 to Bax may be used to gauge the tendency of oocytes and embryos towards either survival or apoptosis. Overall, our results show that apoptosis appears to be an underlying mechanism of bovine oocyte degeneration and embryo fragmentation. Interactions between the Bcl-2 family of proteins may play a critical role in pre-implantation embryo development. These findings could have important implications for improving IVF and related techniques.

Selected single blastocyst transfers maintained pregnancy outcome and eliminated multiple pregnancies.

Background: Transfer of more than one embryo following in vitro fertilization/intracytoplasmic sperm injection cycles have increased pregnancy rate at the cost of increasing the incidence of triplets and twins. It has been proposed that prolonged culture to the blastocyst stage would automatically result in the selection of good quality embryos for transfer and minimize the incidence of triplets and twins. Methods and Results: The objectives of the present retrospective analysis were to examine the pregnancy outcome, multiple pregnancy and related data following: (i) single blastocyst transfer (BT) and double BT; (ii) single BT in patients belonging to different age groups; and (iii) good, fair or poor quality of BT. A total of 260 BT were carried out between August 1998 and July 2002 and they are included in the current study. Sixty of the 260 BT patients received a single BT, and 41 of them received selected single good quality BT (SSBT). The implantation rate has no significant difference between following single BT (53.3%) and double BT (42.8%). No multiple pregnancy occurred following single BT, while significantly higher (P < 0.05) multiple pregnancy rate was observed following a double BT (45.8%). The clinical pregnancy and implantation rates following a single BT were similar (P > 0.05) in patients belonging to <30 years (62.5%), 30-34 years (57.9%) and 35-39 years old (35.8%). Conclusion: Selected single good quality BT maintained pregnancy and avoided multiple pregnancies. It is recommended for patients with a risk for high-order multiple pregnancy. (Reprod Med Biol 2004; 3: 13-18).

Progesterone supplementation before timed AI increased ovulation synchrony and pregnancy per AI, and supplementation after timed AI reduced pregnancy losses in lactating dairy cows.

One of the causes of poor fertility in high producing dairy cows is inadequate progesterone. Therefore, we determined the efficacy of an intravaginal insert containing 1.55 g of progesterone (PRID) given before and/or after timed AI (TAI) on ovarian response, plasma progesterone concentrations, pregnancy per AI (P/AI) and pregnancy losses. Lactating dairy cows at three locations were assigned (Day 0) to an Ovsynch protocol with (N = 294) or without (N = 314) a PRID. The Ovsynch protocol consisted of two injections of 100 µg gonadorelin (GnRH) 9 days apart and one injection of 500 µg cloprostenol (PG) 7 days after the first GnRH treatment. Insertion and removal of PRID occurred concurrent with the first GnRH and PG treatments, respectively. Timed AI was carried out 12 to 16 hours after the second GnRH. Ovarian status of a subset of 217 first service cows had been presynchronized with 2 treatments of PG 14 days apart with the last PG given 12 days before the first GnRH of the Ovsynch protocol. Body condition score (scale of one to five) was recorded at TAI. Ultrasonographic examinations were done in all cows at first GnRH, at PG, at TAI, and 24 hours after TAI for response to treatment and at 32 and 60 days after TAI for confirmation of pregnancy. At 4.5 days after TAI (Day 14), cows that responded to PG and ovulated after the second GnRH treatment were reassigned to receive (N = 223) or not receive (N = 229) a PRID for 7 days. Blood samples were taken for progesterone determination at PG treatment, at TAI, and post TAI on Days 14 and 21. The PRID treatment pre-TAI reduced the percentage of cows ovulating before TAI (5.8% vs. 11.1%), and significantly increased P/AI in nonpresynchronized cows (41.3% vs. 25.1%). Cows ovulating in response to the first GnRH treatment, cyclic cows, and cows with body condition score of 2.75 or more had increased P/AI, but the addition of a PRID pre-TAI to these cows did not increase P/AI. The PRID treatment post TAI did not affect P/AI, but reduced pregnancy losses (6.1% vs. 11.4%) between 32 and 60 days of gestation. The reduction in pregnancy losses tended (P = 0.10) to be significant in acyclic cows receiving a PRID than in those not receiving a PRID (5.6% vs. 33.3%). Plasma progesterone concentrations at PG treatment and on Day 21 (11.5 days after TAI) were linearly associated with P/AI. In conclusion, progesterone supplementation pre-TAI increased P/AI in nonpresynchronized cows. Progesterone supplementation post TAI reduced pregnancy losses, particularly in acyclic cows.

Expression of messenger RNA for ADAMTS subtypes changes in the periovulatory follicle after the gonadotropin surge and during luteal development and regression in cattle.

Extensive remodeling of the extracellular matrix occurs in the ovary during the periovulatory period. Matrix metalloproteinases and their endogenous inhibitors, tissue inhibitors of metalloproteinases, are believed to play integral roles in this highly regulated series of cellular events, but their specific roles remain unclear. Recent cloning studies have identified a novel family of metalloproteinases, the ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) family. The regulated expression of distinct ADAMTS subtypes has been shown to be required for tissue morphogenesis during embryonic development and for maintaining the integrity of tissues in the adult. In the present studies, we have determined that multiple ADAMTS subtypes are present in the bovine ovary using a reverse transcription-polymerase chain reaction strategy. In particular, ADAMTS-1, -2, -3, -4, -5 (also known as ADAMTS-11), -7, -8, and -9, but not ADAMTS-6, -10, or -12, mRNA transcripts were detected in granulosa cells of nonatretic ovarian follicles and corpora lutea. The levels of mRNA for these ovarian ADAMTS were up- or down-regulated or remained unchanged in the granulosa and/or theca cells of the dominant follicle following the preovulatory surge of gonadotropins, depending on the subtype and/or the cell compartment, and in the corpus luteum during the luteal phase of the estrous cycle. The complex expression patterns observed for the distinct ADAMTS subtypes in the granulosa and theca cells of the periovulatory follicle and in the luteal tissues of the bovine ovary suggest that these novel proteases mediate, at least in part, the remodeling events underlying folliculogenesis and ovulation and the formation, maintenance, and regression of the corpus luteum.